Cognitive impairment in arterial hypertension

Abstract

The main manifestation of brain damage in hypertension is cognitive impairment. According to different authors, more than half of patients with hypertension have cognitive impairment beyond the age norm. The presence of causal relationship between cognitive impairment and hypertension is supported by clinical profiles of cognitive disorders and predominantly subcortical impairement: prevaling bradyphrenia, visual-spatial disorders and impaired control functions of the frontal lobes, comorbid emotional disorders. It is recommended for everyday clinical practice to carry out neuropsychological testing of cognitive impairment in patients with hypertension for the timely initiation of therapy. In the treatment of cognitive impairment without dementia, the priority is given to neurometabolic drugs.

Keywords

• артериальная гипертензия
• когнитивные нарушения
• нейрометаболические средства
• актовегин
• hypertension
• cognitive impairment
• neurometabolic drugs
• actovegin